Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Concord Medical Services (NYSE:CCM) in a research note issued to investors on Friday. The firm issued a sell rating on the stock.

Concord Medical Services Price Performance

Concord Medical Services stock opened at $5.07 on Friday. Concord Medical Services has a twelve month low of $3.82 and a twelve month high of $26.70. The company’s 50-day moving average price is $7.25 and its two-hundred day moving average price is $6.68. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.32 and a quick ratio of 0.30.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.